POLYPROX
PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.
POLYPROX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.polyprox.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)1223 804 420
Email Addresses:
[email protected]
Total Funding:
4.4 M GBP
Technology used in webpage:
Pound Sterling GoDaddy
Similar Organizations
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
Current Employees Featured
Founder
Investors List
LifeArc
LifeArc investment in Seed Round - PolyProx
Parkwalk Advisors
Parkwalk Advisors investment in Seed Round - PolyProx
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Seed Round - PolyProx
Future Planet Capital
Future Planet Capital investment in Seed Round - PolyProx
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Seed Round - PolyProx
Rt Capital Management
Rt Capital Management investment in Seed Round - PolyProx
Official Site Inspections
http://www.polyprox.com
- Host name: 109.68.33.64
- IP address: 109.68.33.64
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
